Skip to main content
BOSTON SCIENTIFIC CORP logo

BOSTON SCIENTIFIC CORP — Investor Relations & Filings

Ticker · BSX ISIN · US1011371077 LEI · Y6ZDD9FP4P8JSSJMW954 US Manufacturing
Open in API
Filings indexed 3,157 across all filing types
Latest filing 2022-03-07 Director's Dealing
Country US United States of America
Listing US BSX

About BOSTON SCIENTIFIC CORP

https://www.bostonscientific.com/en-US/…

Boston Scientific Corporation is a global medical technology company that develops, manufactures, and commercializes a broad range of high-performance medical devices. The company's products are used in various minimally invasive, interventional medical specialties, including cardiology, endoscopy, neuromodulation, urology, and pelvic health. Focused on transforming lives through innovative solutions, Boston Scientific is dedicated to improving the health of patients worldwide by addressing complex healthcare challenges and enhancing clinical outcomes.

Recent filings

Filing Released Lang Actions
Director's Dealing 2022
Director's Dealing
2022-03-07 English
424B2
Capital/Financing Update Classification · 100% confidence The document is a prospectus supplement and accompanying prospectus filed pursuant to Rule 424(b)(2) related to a debt securities offering by American Medical Systems Europe B.V., guaranteed by Boston Scientific Corporation. It details the terms of senior notes being offered, including amounts, interest rates, maturity dates, use of proceeds, underwriting, and listing information. The document is a formal offering document for capital raising through debt issuance. It is not a financial report, earnings release, management discussion, or regulatory filing unrelated to financing. The content clearly fits the definition of a Capital/Financing Update (CAP), as it provides detailed information on the company's fundraising and capital structure changes through the issuance of senior notes. The document length (15,000 characters) and detailed content confirm it is the actual offering document, not just an announcement or summary. Therefore, the correct classification is CAP with high confidence.
2022-03-04 English
FWP
Capital/Financing Update Classification · 100% confidence The document is an Issuer Free Writing Prospectus (FWP) filed pursuant to Rule 433 under the Securities Act of 1933. It details terms and conditions for a senior notes offering by American Medical Systems Europe B.V., including principal amounts, maturity dates, coupon rates, and other bond issuance details. The document is a disclosure related to a capital raising activity, specifically a debt offering. It is not a financial report, earnings release, or management discussion. It is not an announcement of a report publication but the actual offering document. Therefore, it fits best under the category of Capital/Financing Update (CAP), which covers updates on company fundraising and financing activities.
2022-03-03 English
Director's Dealing 2022
Director's Dealing
2022-03-03 English
424B5
Capital/Financing Update Classification · 95% confidence The document is a detailed prospectus supplement and accompanying prospectus for a debt securities offering by AMS Europe, a subsidiary of Boston Scientific Corporation. It includes sections such as risk factors, use of proceeds, description of the notes, underwriting, legal matters, and listing information. The document references the Securities and Exchange Commission (SEC) and includes detailed offering terms, underwriting discounts, and legal disclaimers. It is clearly a formal offering document related to capital raising through debt issuance. This matches the definition of a Capital/Financing Update (CAP), which covers updates on company fundraising and financing activities. The document is lengthy (15,000 characters) and contains substantive information about the offering, not merely an announcement or a brief summary. Therefore, it is not a Report Publication Announcement (RPA) or Regulatory Filing (RNS). It is not an annual or interim report, earnings release, or any other category. Hence, the correct classification is CAP with high confidence.
2022-03-03 English
Director's Dealing 2022
Director's Dealing
2022-03-02 English

Browse filings by year

17 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.